← Leaderboards
Jacob D Durrant
University Of Pittsburgh At Pittsburgh
$2,418,301
Attributed
$2,418,301
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $376.2K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,418,301 · 2
By mechanism
R01$1,665,845 · 1
R35$752,456 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Eric Klann$20,406,593
- Ivet Bahar$22,253,131
- Lori A Birder$16,985,823
- Bruce A Mc Clane$13,048,720
- David Ryan Koes$4,131,008
Others in their field
Other Emerging Leaders on “Drug Discovery”
- Leonard Freedman · Leidos Biomedical Research, Inc.$255,277,443
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- John Damon Chodera · Sloan-Kettering Inst Can Research$64,994,606
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Gary Kobinger · University Of Texas Med Br Galveston$41,631,815
Research focus
Drug DiscoveryBasic ScienceComplexStructureAdoptionFlexibilityProtein BiosynthesisPharmaceutical PreparationsProteinsSmall MoleculeCommunitiesDesignBindingInnovationMalignant NeoplasmsLigandsNovel TherapeuticsComputer AssistedBinding ProteinsBeta-LactamaseInfluenzaInterestComputer SoftwareCells
Grant awards (9)
Developing and Applying Accessible Computational Technologies for the Design of Small-Molecule Ligands$376,228
R35 · FY2025 · GM · contact PI
Developing and Applying Accessible Computational Technologies for the Design of Small-Molecule Ligands$376,228
R35 · FY2024 · GM · contact PI
Advancing drug-lead and chemical-probe discovery using weighted-ensemble simulations and biophysical validation$304,514
R01 · FY2023 · GM · contact PI
Advancing drug-lead and chemical-probe discovery using weighted-ensemble simulations and biophysical validation$69,060
R01 · FY2023 · GM · contact PI
Advancing drug-lead and chemical-probe discovery using weighted-ensemble simulations and biophysical validation$304,761
R01 · FY2022 · GM · contact PI
Advancing drug-lead and chemical-probe discovery using weighted-ensemble simulations and biophysical validation$57,475
R01 · FY2022 · GM · contact PI
Advancing drug-lead and chemical-probe discovery using weighted-ensemble simulations and biophysical validation$293,701
R01 · FY2021 · GM · contact PI
Advancing drug-lead and chemical-probe discovery using weighted-ensemble simulations and biophysical validation$306,715
R01 · FY2020 · GM · contact PI
Advancing drug-lead and chemical-probe discovery using weighted-ensemble simulations and biophysical validation$329,619
R01 · FY2019 · GM · contact PI